{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:31:51Z","timestamp":1793831511954,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>There is a limited access to liver transplantation, however, many organs are discarded based on subjective assessment only. Here we report the VITTAL clinical trial (ClinicalTrials.gov number NCT02740608) outcomes, using normothermic machine perfusion (NMP) to objectively assess livers discarded by all UK centres meeting specific high-risk criteria. Thirty-one livers were enroled and assessed by viability criteria based on the lactate clearance to levels \u22642.5\u2009mmol\/L within 4\u2009h. The viability was achieved by 22 (71%) organs, that were transplanted after a median preservation time of 18\u2009h, with 100% 90-day survival. During the median follow up of 542 days, 4 (18%) patients developed biliary strictures requiring re-transplantation. This trial demonstrates that viability testing with NMP is feasible and in this study enabled successful transplantation of 71% of discarded livers, with 100% 90-day patient and graft survival; it does not seem to prevent non-anastomotic biliary strictures in livers donated after circulatory death with prolonged warm ischaemia.<\/jats:p>","DOI":"10.1038\/s41467-020-16251-3","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T12:03:05Z","timestamp":1592308985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":466,"title":["Transplantation of discarded livers following viability testing with normothermic machine perfusion"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5480-9380","authenticated-orcid":false,"given":"Hynek","family":"Mergental","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Thamara P. R.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1709-9284","authenticated-orcid":false,"given":"Yuri L.","family":"Boteon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Attard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0106-5861","authenticated-orcid":false,"given":"Darren","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Curbishley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Wilkhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9800-6811","authenticated-orcid":false,"given":"Desley A. H.","family":"Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"H\u00fcbscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Muiesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Abradelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hentie","family":"Cilliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Bion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9102-6668","authenticated-orcid":false,"given":"Chris","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6715-2514","authenticated-orcid":false,"given":"Christina","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Afford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7531-9089","authenticated-orcid":false,"given":"Darius F.","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"16251_CR1","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(15)00680-7","volume":"386","author":"R Williams","year":"2015","unstructured":"Williams, R. et al. Implementation of the Lancet standing commission on liver disease in the UK. Lancet 386, 2098\u20132111 (2015).","journal-title":"Lancet"},{"key":"16251_CR2","unstructured":"Organ Donation and Transplantation: Annual Report on Liver Transplantation. www.odt.nhs.uk (2016\/2017)."},{"key":"16251_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/ajt.14559","volume":"18","author":"WR Kim","year":"2018","unstructured":"Kim, W. R. et al. OPTN\/SRTR 2016 annual data report: liver. Am. J. Transplant. 18, 172\u2013253 (2018).","journal-title":"Am. J. Transplant."},{"key":"16251_CR4","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMra1507080","volume":"378","author":"SG Tullius","year":"2018","unstructured":"Tullius, S. G. & Rabb, H. Improving the supply and quality of deceased-donor organs for transplantation. N. Engl. J. Med. 378, 1920\u20131929 (2018).","journal-title":"N. Engl. J. Med."},{"key":"16251_CR5","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/S0140-6736(94)90294-1","volume":"344","author":"DF Mirza","year":"1994","unstructured":"Mirza, D. F. et al. Policies in Europe on \u201cmarginal quality\u201d donor livers. Lancet 344, 1480\u20131483 (1994).","journal-title":"Lancet"},{"key":"16251_CR6","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/SLA.0000000000001887","volume":"264","author":"M Ravaioli","year":"2016","unstructured":"Ravaioli, M. et al. Risk avoidance and liver transplantation: a single-center experience in a national network. Ann. Surg. 264, 778\u2013786 (2016).","journal-title":"Ann. Surg."},{"key":"16251_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/SLA.0000000000002305","volume":"268","author":"D Ghinolfi","year":"2018","unstructured":"Ghinolfi, D. et al. Use of elderly donors in liver transplantation: a paired-match analysis at a single center. Ann. Surg. 268, 325\u2013331 (2018).","journal-title":"Ann. Surg."},{"key":"16251_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SLA.0b013e318204e658","volume":"253","author":"CL Jay","year":"2011","unstructured":"Jay, C. L. et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann. Surg. 253, 259\u2013264 (2011).","journal-title":"Ann. Surg."},{"key":"16251_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/00007890-199304000-00024","volume":"55","author":"RJ Ploeg","year":"1993","unstructured":"Ploeg, R. J. et al. Risk factors for primary dysfunction after liver transplantation\u2014a multivariate analysis. Transplantation 55, 807\u2013813 (1993).","journal-title":"Transplantation"},{"key":"16251_CR10","unstructured":"Annual report on liver transplantation 2018\/19. NHS Blood and Transplant. www.odt.nhs.uk."},{"key":"16251_CR11","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/SLA.0b013e3182365081","volume":"254","author":"P Dutkowski","year":"2011","unstructured":"Dutkowski, P. et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann. Surg. 254, 745\u2013753 (2011). discussion 753.","journal-title":"Ann. Surg."},{"key":"16251_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/TP.0000000000002127","volume":"102","author":"F Marcon","year":"2018","unstructured":"Marcon, F. et al. Utilisation of declined liver grafts yields comparable transplant outcomes and previous decline should not be a deterrent to graft use. Transplantation 102, 211\u2013218 (2018).","journal-title":"Transplantation"},{"key":"16251_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431\u2013435 (2014).","journal-title":"Nature"},{"key":"16251_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","volume":"557","author":"D Nasralla","year":"2018","unstructured":"Nasralla, D. et al. A randomized trial of normothermic preservation in liver transplantation. Nature 557, 50\u201356 (2018).","journal-title":"Nature"},{"key":"16251_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/lt.25291","volume":"24","author":"H Mergental","year":"2018","unstructured":"Mergental, H. et al. Development of clinical criteria for functional assessment to predict primary nonfunction of high-risk livers using normothermic machine perfusion. Liver Transpl. 24, 1453\u20131469 (2018).","journal-title":"Liver Transpl."},{"key":"16251_CR16","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1111\/ajt.13875","volume":"16","author":"H Mergental","year":"2016","unstructured":"Mergental, H. et al. Transplantation of declined liver allografts following normothermic ex-situ evaluation. Am. J. Transpl. 16, 3235\u20133245 (2016).","journal-title":"Am. J. Transpl."},{"key":"16251_CR17","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1111\/ajt.14687","volume":"18","author":"CJE Watson","year":"2018","unstructured":"Watson, C. J. E. et al. Observations on the ex situ perfusion of livers for transplantation. Am. J. Transplant.18, 2005\u20132020 (2018).","journal-title":"Am. J. Transplant."},{"key":"16251_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/TP.0b013e318225db4d","volume":"92","author":"K Barber","year":"2011","unstructured":"Barber, K. et al. Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. Transplantation 92, 469\u2013476 (2011).","journal-title":"Transplantation"},{"key":"16251_CR19","unstructured":"Taking Organ Utilisation to 2020: ODT Organ Utilisation Strategy. NHS Blood and Transplant. www.odt.nhs.uk."},{"key":"16251_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.1600-6143.2006.01242.x","volume":"6","author":"S Feng","year":"2006","unstructured":"Feng, S. et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am. J. Transplant. 6, 783\u2013790 (2006).","journal-title":"Am. J. Transplant."},{"key":"16251_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/TP.0000000000002466","volume":"103","author":"I Linares","year":"2019","unstructured":"Linares, I., Hamar, M., Selzner, N. & Selzner, M. Steatosis in liver transplantation: current limitations and future strategies. Transplantation 103, 78\u201390 (2019).","journal-title":"Transplantation"},{"key":"16251_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/TP.0b013e3181e86b11","volume":"90","author":"J Briceno","year":"2010","unstructured":"Briceno, J., Ciria, R., de la Mata, M., Rufian, S. & Lopez-Cillero, P. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era. Transplantation 90, 530\u2013539 (2010).","journal-title":"Transplantation"},{"key":"16251_CR23","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/lt.24484","volume":"22","author":"G de la Rosa","year":"2016","unstructured":"de la Rosa, G., Fondevila, C. & Navasa, M. Liver transplantation in Spain. Liver Transplant. 22, 1259\u20131264 (2016).","journal-title":"Liver Transplant."},{"key":"16251_CR24","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/lt.24865","volume":"24","author":"A Schlegel","year":"2018","unstructured":"Schlegel, A. et al. Impact of donor age in donation after circulatory death liver transplantation: Is the cutoff \u201c60\u201d still of relevance? Liver Transplant. 24, 352\u2013362 (2018).","journal-title":"Liver Transplant."},{"key":"16251_CR25","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/lt.25584","volume":"25","author":"CDL Ceresa","year":"2019","unstructured":"Ceresa, C. D. L., et al. Transient cold storage prior to normothermic liver perfusion may facilitate adoption of a novel technology. Liver Transplant. 25, 1503\u20131513 (2019).","journal-title":"Liver Transplant."},{"key":"16251_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/SLA.0000000000001834","volume":"265","author":"CJ Watson","year":"2017","unstructured":"Watson, C. J. et al. 26-Hour storage of a declined liver before successful transplantation using ex vivo normothermic perfusion. Ann. Surg. 265, e1\u2013e2 (2017).","journal-title":"Ann. Surg."},{"key":"16251_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jhep.2017.10.034","volume":"68","author":"A Schlegel","year":"2018","unstructured":"Schlegel, A. et al. The UK DCD risk score: a new proposal to define futility in donation-after-circulatory-death liver transplantation. J. Hepatol. 68, 456\u2013464 (2018).","journal-title":"J. Hepatol."},{"key":"16251_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/SLA.0b013e3182104784","volume":"253","author":"DP Foley","year":"2011","unstructured":"Foley, D. P. et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann. Surg. 253, 817\u2013825 (2011).","journal-title":"Ann. Surg."},{"key":"16251_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jhep.2013.11.023","volume":"60","author":"P Dutkowski","year":"2014","unstructured":"Dutkowski, P. et al. HOPE for human liver grafts obtained from donors after cardiac death. J. Hepatol. 60, 765\u2013772 (2014).","journal-title":"J. Hepatol."},{"key":"16251_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jhep.2018.12.013","volume":"70","author":"AJ Hessheimer","year":"2019","unstructured":"Hessheimer, A. J. et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. J. Hepatol. 70, 658\u2013665 (2019).","journal-title":"J. Hepatol"},{"key":"16251_CR31","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1097\/TP.0000000000002127","volume":"102","author":"F Marcon","year":"2018","unstructured":"Marcon, F. et al. Utilization of declined liver grafts yields comparable transplant outcomes and previous decline should not be a deterrent to graft use. Transplantation 102, e211\u2013e218 (2018).","journal-title":"Transplantation"},{"key":"16251_CR32","doi-asserted-by":"crossref","first-page":"e017733","DOI":"10.1136\/bmjopen-2017-017733","volume":"7","author":"RW Laing","year":"2017","unstructured":"Laing, R. W. et al. Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial. BMJ Open 7, e017733 (2017).","journal-title":"BMJ Open"},{"key":"16251_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/lt.22091","volume":"16","author":"KM Olthoff","year":"2010","unstructured":"Olthoff, K. M. et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transplant. 16, 943\u2013949 (2010).","journal-title":"Liver Transplant."},{"key":"16251_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo, D., Demartines, N. & Clavien, P. A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 240, 205\u2013213 (2004).","journal-title":"Ann. Surg."},{"key":"16251_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon, R. Optimal two-stage designs for phase II clinical trials. Controlled Clin. Trials 10, 1\u201310 (1989).","journal-title":"Controlled Clin. Trials"},{"key":"16251_CR36","unstructured":"Interim Report on Liver Transplantation: Report for 2014\/15. www.odt.nhs.uk."},{"key":"16251_CR37","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1002\/(SICI)1097-0258(19971215)16:23<2701::AID-SIM704>3.0.CO;2-1","volume":"16","author":"TT Chen","year":"1997","unstructured":"Chen, T. T. Optimal three-stage designs for phase II cancer clinical trials. Stat. Med. 16, 2701\u20132711 (1997).","journal-title":"Stat. Med."},{"key":"16251_CR38","doi-asserted-by":"crossref","unstructured":"Dutkowski, P. et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann. Surg. 256, 861\u2013869 (2012).","DOI":"10.1097\/SLA.0b013e318272dea2"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16251-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:24:13Z","timestamp":1723044253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16251-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16251"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16251-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"30 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.J.F. is a co-founder, chief medical officer and consultant to OrganOx Ltd and also holds shares in the company, he was involved in the study design and funding application, but was not involved in the conduct of the clinical trial. C.M. is an OrganOx Ltd employee and provided the device technical support. H.M. received consultancy fees for lecturing and training activities for OrganOx Ltd. All other co-authors declare no competing interests. This paper presents independent research supported by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2939"}}